Marijuana effectiveness as an HIV self-care strategy

Clinical Nursing Research

Volumn 18, Issue 2, 2009, Pages 172-193

  Corless, Inge B ^a   Lindgren, Teri ^b   Holzemer, William ^b   Robinson, Linda ^c   Moezzi, Shahnaz ^d   Kirksey, Kenn ^e   Coleman, Christopher ^f   Tsai, Yun Fang ^g   Sanzero Eller, Lucille ^h   Hamilton, Mary Jane ⁱ   Sefcik, Elizabeth F ⁱ   Canaval, Gladys E ^j   Rivero Mendez, Marta ^k   Kemppainen, Jeanne K ^l   Bunch, Eli H ^m   Nicholas, Patrice K ⁿ   Nokes, Kathleen M ^o   Dole, Pamela ^p   Reynolds, Nancy ^q  

^a MGH INSTITUTE OF HEALTH PROFESSIONS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SAN DIEGO   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e SETON FAMILY OF HOSPITALS   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g CHANG GUNG UNIVERSITY   (Taiwan)

^h RUTGERS UNIVERSITY   (United States)

ⁱ TEXAS A AND M UNIVERSITY   (United States)

^j UNIVERSIDAD DEL VALLE   (Colombia)

^k UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^l UNIVERSITY OF NORTH CAROLINA WILMINGTON   (United States)

^m UNIVERSITY OF OSLO   (Norway)

ⁿ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^o CITY UNIVERSITY OF NEW YORK   (United States)

^p Yale University ^*

^q YALE UNIVERSITY   (United States)

more..

Author keywords

HIV AIDS; Marijuana; Symptom management

Indexed keywords

ARTICLE; CANNABIS SMOKING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOPHYSIOLOGY; PHYTOTHERAPY; SELF CARE;

HIV INFECTIONS; HUMANS; MARIJUANA SMOKING; PHYTOTHERAPY; SELF CARE;

EID: 65249173894     PISSN: 10547738     EISSN: 15523799     Source Type: Journal    
DOI: 10.1177/1054773809334958     Document Type: Article

References (54)

1. Abrams, D.I., Jay, C.A., Shade, S.B., Vizoso, H., Reda, H., Press, S., et al. (2007). Cannabis in painful HIV-associated sensory neuropathy. Neurology, 68, 515-521.
2. Beal, J.E., Olson, R., Lefkowitz, L., Laubenstein, L., Bellman, P., Bienvenido, Y., et al. (1997). Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. Journal of Pain and Symptom Management, 14, 7-14. (Pubitemid 27287406)
3. Braitstein, P., Kendall, T., Chan, K., Wood, E., Montaner, J.S., O'Shaughnessy, M.V., et al. (2001). Mary-Jane and her patients: Sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents. AIDS, 15, 532-533. (Pubitemid 32207577)
4. Chander, G., Himmelboch, S., & Moore, R.D. (2006). Substance abuse and psychiatric disorders in HIV-positive patients: Epidemiology and impact on antiretroviral therapy. Drugs, 66, 769-789. (Pubitemid 43765224)
5. Chesney, M.A., Ickovics, J.R., Chambers, D.B., Gifford, A.L., Neidig, J., Zwick, L.B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12, 255-266.
6. Corless, I.B., Lindgren, T., Robinson, L., Moezzi, S., Holzemer, W.L., Kirksey, K.M., et al. (2006, August). Use and perceived effectiveness of marijuana and medications as a self-care strategy for six symptoms. Poster session presented at the XV1 International AIDS Conference, Toronto, Ontario, Canada.
7. Corless, I.B., & Miramontes, H.M. (1997). Is it better to inhale? An examination of the medical use of marijuana controversy in the United States. Journal of the Association of Nurses in AIDS Care, 8 (3). 17-18.
8. Cristiani, S.A., Pukay-Martin, N.D., & Bornstein, R.A. (2004). Marijuana use and cognitive function in HIV-infected people. Journal of Neuropsychiatry and Clinical Neurosciences, 16, 330-335. (Pubitemid 39244559)
9. de Jong, B.C., Prentiss, D., McFarland, W., Machekano, R., & Israelski, D.M. (2005). Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. Journal of Acquired Immune Deficiency Syndromes, 38 (1). 43-46. (Pubitemid 40094117)
10. Fairfield, K.M., Eisenberg, D.M., Davis, R.B., Libman, H., & Phillips, R.S. (1998). Patterns of use, expenditures, and perceived efficacy of complementary therapies in HIV-infected patients. Archives of Internal Medicine, 158, 2257-2264. (Pubitemid 28512500)
11. Fogarty, A., Rawstorne, P., Prestage, G., Crawford, J., Grierson, J., & Kippax, S. (2007). Marijuana as therapy for people living with HIV/AIDS: Social and health aspects. AIDS Care, 19, 295-301. (Pubitemid 46276022)
12. Fuerst, M.L. (2006). New data find no lung cancer link for marijuana. Oncology Times, 38 (12). 30-31.
13. Gorter, R.W., Butorac, M., Cobian, E.P., & van der Sluis, W. (2005). Medical use of cannabis in the Netherlands. Neurology, 64, 917-919. (Pubitemid 40316341)
14. Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42, 327-360. (Pubitemid 36433875)
15. Grucza, R.A., Abbacchi, A.M., Przybeck, T.R., & Gfoerer, J.C. (2007). Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys. Addiction, 102, 623-629. (Pubitemid 46398838)
16. Hanna, L. (1997, June). Nausea and vomiting. Bulletin of Experimental Treatments for AIDS. Retrieved January 3, 2008, from http://www.aegis.com/pubs/ beta/1997/BE970603.htm (Pubitemid 37500449)
17. Haney, M., Rabkin, J., Gunderson, E., & Foltin, R.W. (2005). Dronabinol and marijuana in HIV(+) marijuana smokers: Acute effects on caloric intake and mood. Psychopharmacology, 181, 170-178. (Pubitemid 41440928)
18. Harder, V.S., Morral, A.R., & Arkes, J. (2006). Marijuana use and depression among adults: Testing for causal associations. Addiction, 101, 1463-1472. (Pubitemid 44337771)
19. Hashibe, M., Strait, K., Tashkin, D.P., Morgenstern, H., Greenland, S., & Zhang, Z.F. (2005). Epidemiologic review of marijuana use and cancer risk. Alcohol, 35, 265-275. (Pubitemid 41079926)
20. Holmes, W.C., & Shea, J.A. (1998). A new HIV/AIDS-targeted quality of life (HAT-QoL) instrument: Development, reliability, and validity. Medical Care, 36, 138-154. (Pubitemid 128454305)
21. Holmes, W.C., & Shea, J.A. (1999). Two approaches to measuring quality of life in the HIV/ AIDS population: HAT-QoL and MOS-HIV. Quality of Life Research, 8, 515-527. (Pubitemid 29470621)
22. Holzemer, W.L., Bakken, S., Portillo, C.J., Grimes, R., Welch, J., Wantland, D., et al. (2006). Testing a nurse-tailored HIV medication adherence intervention. Nursing Research, 55, 189-197.
23. Holzemer, W.L., Corless, I.B., Nokes, K.M., Turner, J.G., Brown, M.A., Powell-Cope, G.M., et al. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care and STDs, 13, 185-197. (Pubitemid 29155987)
24. Holzemer, W.L., Henry, S.B., Portillo, C.J., & Miramontes, H. (2000). The Client Adherence Profiling-Intervention Tailoring (CAP-IT) intervention for enhancing adherence to HIV/ AIDS medications: A pilot study. Journal of the Association of Nurses in AIDS Care, 11 (1). 36-44.
25. Holzemer, W.L., Hudson, A., Kirksey, K.M., Hamilton, M.J., & Bakken, S. (2001). The revised Sign and Symptom Check-List for HIV (SSC-HIVrev). Journal of the Association of Nurses in AIDS Care, 12 (5). 60-70.
26. Howard, J., Anie, K.A., Holdcroft, A., Korn, S., & Davies, S.C. (2005). Cannabis use in sickle cell disease: A questionnaire study. British Journal of Haematology, 131, 123-128. (Pubitemid 43899717)
27. Jager, G., Van Hell, H.H., De Win, M.M., Kahn, R.S., Van Den Brink, W., & Van Ree, J.M. (2007). Effects of frequent cannabis use on hippocampal activity during an associative memory task. European Neuropsychopharmacology, 17, 289-297. (Pubitemid 46156994)
28. Kosel, B.W., Aweeka, F.T., Benowitz, N.L., Shade, S.B., Hilton, J.F., Lizak, P.S., et al. (2002). The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir. AIDS, 16, 543-550. (Pubitemid 34218849)
29. Kuo, W.-H., Gallo, J.J., & Tien, A.Y. (2001). Incidence of suicide ideation and attempts in adults: The 13-year follow-up of a community sample in Baltimore, Maryland. Psychological Medicine, 31, 1181-1191. (Pubitemid 32975883)
30. Linszen, D., & van Amelsvoort, T. (2007). Cannabis and psychosis: An update on course and biological plausible mechanisms. Current Opinion in Psychiatry, 20, 116-120. (Pubitemid 46215416)
31. Moore, T.H.M., Zammit, S., Lingford-Hughes, A., Barnes, T.R.E., Jones, P.B., Burke, M., et al. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet, 370, 319-328. (Pubitemid 47094993)
32. Namin, F., Patel, J., Lin, Z., Sarosiek, I., Foran, P., Esmaelli, P., et al. (2007). Clinical, psychiatric, and manometric profile of cyclic vomiting syndrome in adults and response to tricyclic therapy. Neurogastroenterology & Motility, 19, 196-202. (Pubitemid 46239431)
33. Nicholas, P.K., Kemppainen, J.K., Canaval, G.E., Corless, I.B., Sefcik, E.F., Nokes, K.M., et al. (2007). Symptom management and self-care for peripheral neuropathy in HIV/AIDS. AIDS Care, 19, 179-189. (Pubitemid 46269514)
34. Okie, S. (2005). Medical marijuana and the Supreme Court. New England Journal of Medicine, 353, 648-651. (Pubitemid 41175672)
35. O'Leary, D.S., Block, R.I., Koeppel, J.A., Schultz, S.K., Magnotta, V.A., Ponto, L.B., et al. (2007). Effects of smoking marijuana on focal attention and brain blood flow. Human Psychopharmacology: Clinical and Experimental, 22, 135-148. (Pubitemid 46730582)
36. Peretti-Watel, P., Spire, B., Lert, F., Obadia, Y., & VESPA Group (2006). Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003). Drug and Alcohol Dependence, 82 (Suppl. 1). S71 - S79. (Pubitemid 43850179)
37. Phaladze, N.A., Human, S., Dlamini, S.B., Hulela, E.B., Hadebe, I.M., Sukati, N.A., et al. (2005). Quality of life and the concept of "living well" with HIV/AIDS in sub-Saharan Africa. Journal of Nursing Scholarship, 37, 120-126. (Pubitemid 41638481)
38. Pitts, M., Grierson, J., & Misson, S. (2005). Growing older with HIV: A study of health, social and economic circumstances for people living with HIV in Australia over the age of 50 years. AIDS Patient Care and STDs, 19, 460-465. (Pubitemid 41105526)
39. Pollack, H.A., & Reuter, P. (2006). The implications of recent findings on the link between cannabis and psychosis. Addiction, 102, 173-176.
40. Prentiss, D., Power, R., Balmas, G., Tzuang, G., & Israelski, D.M. (2004). Patterns of marijuana use among patients with HIV/AIDS followed in a public health setting. Journal of Acquired Immune Deficiency Syndromes, 35 (1). 38-45. (Pubitemid 38044780)
41. Radey, M., & Hopson, L. (2007). Cannabis-related disorders. In B. A. Thyer & J. S. Wodarski (Eds.), Social work in mental health: An evidence-based approach (pp. 183-200). Hoboken, NJ: Wiley.
42. Robson, P. (2005). Human studies of cannabinoids and medicinal cannabis. Handbook of Experimental Pharmacology, 168, 719-756.
43. Rose, J.S., Herman, D.S., Hagerty, C., Phipps, M.G., Peipert, J.F., & Stein, M.D. (2007). Marijuana use among young women in a primary care setting. Journal of General Internal Medicine, 22, 826-829. (Pubitemid 46763973)
44. Sidney, S. (2001). Marijuana use in HIV-positive and AIDS patients: Results of an anonymous mail survey. Journal of Cannabis Therapeutics, 1 (3 / 4). 35-41.
45. Stinson, F.S., Ruan, W.J., Pickering, R., & Grant, B.F. (2006). Cannabis use disorders in the USA: Prevalence, correlates and co-morbidity. Psychological Medicine, 36, 1447-1460. (Pubitemid 44355980)
46. Tetrault, J.M., Crothers, K., Moore, B.A., Mehra, R., Concata, J., & Fielin, D.A. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review. Archives of Internal Medicine, 167, 221-228. (Pubitemid 46256538)
47. Tucker, J.S., Burnam, M.A., Sherbourne, C.D., Kung, F.-Y., & Gifford, A.L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. American Journal of Medicine, 114, 573-580. (Pubitemid 36577260)
48. Wantland, D.J., Holzemer, W.L., Moezzi, S., Willard, S., Arudo, J., Kirksey, K.M., et al. (2008). A RCT testing the efficacy of an HIV/AIDS symptom management manual. Journal of Pain and Symptom Management, 3, 235-246.
49. Ware, M.A. (2006). Is there a role for marijuana in medical practice ? CFP-MFC, 52, 1531-1533. (Pubitemid 46021175)
50. Ware, M.A., Adams, H., & Guy, G.W. (2005). The medicinal use of cannabis in the U.K.: Results of a nationwide survey. International Journal of Clinical Practice, 59, 291-295. (Pubitemid 40352745)
51. Ware, M.A., Rueda, S., Singer, J., & Kilby, D. (2003). Cannabis use by persons living with HIV/AIDS: Patterns and prevalence of use. Journal of Cannabis Therapeutics, 3 (2). 3-15. (Pubitemid 36889409)
52. Watson, S.J., Benson, J.A., & Joy, J.E. (2000). Marijuana and medicine: Assessing the science base. A Summary of the 1999 Institute of Medicine Report. Archives of General Psychiatry, 57, 547-552. (Pubitemid 30349434)
53. Wilson, K.J., Doxanakis, A., & Fairley, C.K. (2004). Predictors for non-adherence to antiretroviral therapy. Sexual Health, 1, 251-257.
54. Woolridge, E., Barton, S., Samuel, J., Osorio, J., Dougherty, A., & Holdcroft, A. (2005). Cannabis use in HIV for pain and other medical symptoms. Journal of Pain and Symptom Management, 29, 358-367. (Pubitemid 40602516)